BJRI
BJ's Restaurants, Inc.
BJRI has the edge over NKE overall, supported by stronger fundamentals and stronger modeled upside.
NKE
NIKE, Inc.
NKE has slightly lower modeled downside risk, despite its lower overall score.
BJRI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
BJRI's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
BJRI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 20x | $42.55 | -22% |
| Current | 26x | $54.89 | — |
| Fair | 32x | $66.37 | +21% |
| Expensive | 51x | $108 | +96% |
Historical ranges are pointers, not guarantees.
BJRI's PE is in its cheap range at 26x.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over BJRI in the historical PE scenario, which offers more potential upside but is not a forecast.
BJRI Forward outlook
There aren't enough analyst estimates for BJRI to show an outlook.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
BJRI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.10 | +54% |
| Q2 2026 | $1.88 | +55% |
| Q1 2026 | $1.99 | +107% |
| Q4 2025 | $2.16 | +209% |
| Q3 2025 | $1.36 | +9.7% |
| Q2 2025 | $1.21 | 0% |
| Q1 2025 | $0.96 | -3% |
| Q4 2024 | $0.70 | -15% |
BJRI has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
BJRI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $358.6M | +8.6% |
| Q2 2026 | $388.9M | +6.4% |
| Q1 2026 | $358.1M | +2.9% |
| Q4 2025 | $355.4M | +3.2% |
| Q3 2025 | $330.2M | +1.4% |
| Q2 2025 | $365.6M | +4.5% |
| Q1 2025 | $348M | +3.2% |
| Q4 2024 | $344.3M | +6.4% |
BJRI has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +1.8 points |
| Q2 2026 | 4.7% | -1.1 points |
| Q1 2026 | 3% | -1.3 points |
| Q4 2025 | 3.1% | +4.5 points |
| Q3 2025 | -0.3% | +0.5 points |
| Q2 2025 | 5.8% | +2 points |
| Q1 2025 | 4.3% | +1.8 points |
| Q4 2024 | -1.4% | -2.4 points |
BJRI's operating margin was 1.5% last quarter, up 1.8 points from the same quarter a year ago.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over BJRI on profitability, with a higher operating margin.
BJRI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $22.2M | +515% |
| Q2 2026 | $7.7M | -82% |
| Q1 2026 | $27.2M | +$39.2M |
| Q4 2025 | $7.5M | -53% |
| Q3 2025 | $3.6M | -53% |
| Q2 2025 | $41.9M | +5601% |
| Q1 2025 | -$12.1M | -2792% |
| Q4 2024 | $15.8M | +3.1% |
BJRI has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
BJRI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.2% | +693K shares |
| 1 year | +0.4% | +99K shares |
| 3 years | -4.1% | -960K shares |
| 5 years | -3% | -708K shares |
| Available history | +9.7% | +2M shares |
BJRI has 23M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1M |
| Q2 2026 | $2.4M |
| Q1 2026 | $5.3M |
| Q4 2025 | $5.4M |
| Q3 2025 | $33.2M |
| Q2 2025 | $15.1M |
| Q1 2025 | $14.1M |
| Q4 2024 | $8M |
BJRI spent $14M buying back its own shares over the past year, down 80% from the year before.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has the edge over BJRI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
BJRI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.0x | Very low |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.7x | Very low |
| Q4 2024 | 0.5x | Very low |
BJRI has the edge over NKE on leverage, with a lower net debt burden relative to earnings.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
BJRI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 16.3 | Oversold |
BJRI's weekly RSI is 47 (neutral) and its Stochastic is 16 (oversold).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
BJRI PE vs Consumer Cyclical Sector
| Metric | BJRI | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 18x | 45% above |
| PE % | 27 | 47 | 20 pts below |
BJRI is trading at 26x earnings, a 45% premium to the Consumer Cyclical sector's median of 18x.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE has the edge over BJRI on valuation relative to its sector.
BJRI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $58.9 | 6.7% below |
| 20 week MA | $62.2 | 12% below |
| 50 week MA | $49.9 | 10% above |
| 100 week MA | $43.1 | 27% above |
| 200 week MA | $37.7 | 46% above |
BJRI has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
BJRI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.4 | $39.1 | +4.5% |
| 2021 | $39.1 | $36.1 | -7.6% |
| 2022 | $36.1 | $27.8 | -23% |
| 2023 | $27.8 | $36.0 | +30% |
| 2024 | $36.0 | $34.7 | -3.5% |
| 2025 | $34.7 | $41.2 | +19% |
| 2026 YTD | $41.2 | $54.9 | +33% |
BJRI has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.